Silver Book

Silver Book Fact

Infection control program reduced hospital-acquired HAIs by > 1/3

A multimodal infection control program reduced the rate of hospital-acquired HAIs by more than 1/3 and improved quality of care and patient outcomes.

Ebnother C, Tanner B, Schmid F, La Rocca V, et al. Impact of an Infection Control Program on the Prevalence of Nonsocomial Infections at a Tertiary Care Center in Switzerland. Infect Control Hosp Epidemiol. 2008; 29(1): 38-43. https://www.cambridge.org/core/journals/infection-control-and-hospital-epidemiology/article/impact-of-an-infection-control-program-on-the-prevalence-of-nosocomial-infections-at-a-tertiary-care-center-in-switzerland/DD00D109FCFE36F69E9D89BD1DE9F8A4

Reference

Title
Impact of an Infection Control Program on the Prevalence of Nonsocomial Infections at a Tertiary Care Center in Switzerland
Publication
Infect Control Hosp Epidemiol
Publication Date
2008
Authors
Ebnother C, Tanner B, Schmid F, La Rocca V, et al.
Volume & Issue
Volume 29, Issue 1
Pages
38-43
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Publications

Healthcare-Associated Infections Factsheet

 https://www.silverbook.org/wp-content/uploads/2015/06/Screen-Shot-2015-06-30-at-3.02.28-PM.png Thumbnail

Related Facts

  • New antibacterial agents between 1983 and 2012
    Total number of new antibacterial agents is in decline  
  • Reduction in hospital-acquired HAIs could produce significant savings
    Practices that lead to a 20% reduction in preventable hospital-acquired HAIs would save up to $6.8 billion in medical costs. a 70% reduction would lead to a savings of up…  
  • An antibiotic stewardship program saved $17 million over 8 years
    An antibiotic stewardship program saved a total of $17 million over 8 years, with antibiotic costs rising $1 million in the first year after discontinuation.  
  • Pre-surgery antibiotic use reduces 6-day mortality by 50% in elderly
    Effective pre-surgery antibiotic use can reduce 60-day mortality in the elderly by 50%.  
  • Negative value of antibiotics to drug companies
    The value of an antibiotic to a drug company is negative $50 million- compared to the positive value of $1 billion for a new musculoskeletal drug.